PriceSensitive

Ventripoint sells two VMS+ cardiac imaging systems for donation

Market News
TSXV:VPT
19 November 2026 09:00 (EST)

Source: Stock image generated with AI.

Key Highlights

Ventripoint Diagnostics Ltd. (TSXV: VPT; OTC: VPTDF) says it has sold two VMS+ cardiac imaging systems that will be donated in honour of Ella’s Umbrella, with the placements aimed at supporting clinical research and the use of advanced cardiac imaging in routine care.

According to the company, one of the systems is planned to support a study involving pregnant women with congenital heart disease, a group it said may face additional demands on the heart during pregnancy.

This article is a journalistic opinion piece which has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.

Ventripoint said the second VMS+ system will be deployed in routine clinical practice, with the goal of gathering practical insights into how the technology can be incorporated into established cardiology workflows, including its potential to improve clinical efficiency and streamline cardiac assessment.

VMS+ uses Ventripoint’s Knowledge-Based Reconstruction (KBR) technology to convert standard two-dimensional echocardiography images into three-dimensional cardiac models, providing volumetric measurements of all four heart chambers. The company said the technology is designed to work with existing ultrasound equipment.

In a statement, President and Chief Executive Officer Hugh MacNaught said, “We’re pleased to see two VMS+ systems donated in honor of Ella’s Umbrella, an organization that understands firsthand how important advances in cardiac care can be.”

Ventripoint expects the experience gained through the research and routine clinical applications to help inform future deployments and support broader acceptance of VMS+ within the cardiology community.

Ella’s Umbrella is a nonprofit founded in memory of Ella Mertens, who died in 2017 from an undiagnosed heart condition, according to the release.

Read the original press release on Stockhouse.com.

Related News